References
1. Seethala RR, Stenman G. Update from the 4th edition of the World
Health Organization classification of head and neck tumours: tumors of
the salivary gland. Head Neck Pathol . 2017;11(1):55-67. doi:
10.1007/s12105-017-0795-0
2. Urano M, Nakaguro M, Yamamoto Y, et al. Diagnostic significance of
HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad
histopathologic spectrum. Am J Surg Pathol. 2019;43(7):984-994. doi:
10.1097/PAS.0000000000001258
3. Skalova A, Leivo I, Hellquist H, et al. High-grade
transformation/dedifferentiation in salivary gland carcinomas:
occurrence across subtypes and clinical significance. Adv Anat Pathol.
2021;28(3):107-18. doi: 10.1097/PAP.0000000000000298.
4. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma:
a review of the clinicopathologic spectrum and immunophenotypic
characteristics in 61 tumors of the salivary glands and upper
aerodigestive tract. Am J Surg Pathol. 2007;31(1):44-57. doi:
10.1097/01.pas.0000213314.74423.d8.